Carvedilol Tablet, Film Coated
Product Images NDC 68071-3970

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68071-3970). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3970 6)

Pdp (68071 3970 6)
This is the product information for Carvedilol tablets, 3.125mg from NuCare Pharmaceuticals, Inc. The package contains 60 tablets. It is recommended to store the product at a controlled temperature between 53-86°F and keep it out of reach of children.*
FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)
This description provides categories such as gender, age, race, health conditions, heart rate, blood pressure levels, and medication status for evaluating various factors including ischemic conditions, diabetes, and the use of spironolactone in patients. The text also includes terms like "Hazard ratio" suggesting a statistical calculation may be involved in the evaluation process.*
FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)
This text provides information related to a clinical study or trial, specifying criteria such as age, gender, time frames for treatment interventions, presence of prior conditions or medications, and various health parameters such as heart rate, blood pressure, and specific health conditions like angina or diabetes. It also mentions terms like hazard ratio, CHF (congestive heart failure), diuretics, hypertension, and thrombolytic therapy. The text outlines factors to be considered for different treatment approaches in patients meeting these criteria.*
FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.